SYGNIS AG successfully completes Rights Offering and Private Placement * Rights offering and private placement significantly oversubscribed * Acquisition of Innova Biosciences Ltd. secured * Gross proceeds of EUR 10 million to cover transaction and integration costs and working capital Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced […]
CAMBRIDGE, MA — Ovation Life Sciences, LLC (Ovation) announced today the receipt of 1.5 million dollars in funding from StageDotO, and existing investors, including Longfellow Ventures. The company will use the funds to continue the development of its next-generation scientific data-layer-as-a-service platforms, built to accelerate the progress of life science by improving how the story of […]
SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd. Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today received a binding commitment for the purchase of shares […]
– Contributing to people’s health by promoting the spread of genetic testing equipment in the healthcare field – Tokyo, Japan: Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) agreed to start a capital and business alliance (hereinafter, “the Alliance”) with Precision System Science Co., Ltd. (PSS) relating to the genetic testing business using the PCR*¹ method. […]
Precision System Science, Co., Ltd. (“PSS”) hereby announces that its Board of Directors has resolved at the meeting held on May 15, 2017 to conclude a capital and business alliance with Hitachi High-Technologies Corporation (“Hitachi High-Tech”) (this alliance hereinafter referred to as the “Capital and Business Alliance”) and to issue new shares through a third-party […]
Revenue rises to over EUR 2.5 billion – EBIT reaches EUR 384 million All segments contributed to this positive trend Position as market leader reinforced Asia continues to ensure dynamic growth Demand for digital solutions increases Positive outlook for second half of fiscal year OBERKOCHEN/Germany The ZEISS Group had a very successful end to the […]
New investor Dell Technologies Capital leads round; all existing investors participate SAN DIEGO – Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN™ platform, an end-to-end solution for analysis of next-generation sequencing data. New investor Dell Technologies Capital, the venture arm […]
Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction […]
Cambridge, UK – Congenica, a world leader in clinical genomics software for inherited diseases, today announced completion of its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), another well-established China-based life-science investor and Future Planet Capital, a global […]
CARLSBAD, Calif. — ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Series B funding. This latest round is led by New Enterprise Associates (NEA) with participation from existing investors Domain Associates, who led the Company’s Series A round in 2015, and Okapi Ventures. The funding will be used to fuel development […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
